Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.610
+0.090 (5.92%)
Jan 22, 2026, 2:57 PM EST - Market open
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $45.05 million as of January 22, 2026. Its market cap has decreased by -84.41% in one year.
Market Cap
45.05M
Enterprise Value
-4.98M
1-Year Change
-84.41%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $45.05M, a decrease of -63.30%. That is a compound annual growth rate of -15.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 42.54M | -16.94% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 46.07M |
| NextCure | 45.89M |
| CEL-SCI | 45.41M |
| Kezar Life Sciences | 45.31M |
| Anebulo Pharmaceuticals | 44.37M |
| Tvardi Therapeutics | 43.89M |
| INmune Bio | 42.80M |
| TuHURA Biosciences | 42.40M |